These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1686713)

  • 1. Immunoblot detection of P-glycoprotein in human tumors and cell lines.
    Fredericks WJ; Chen YF; Baker RM
    Cancer Treat Res; 1991; 57():121-49. PubMed ID: 1686713
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of the MDR1 gene in human cancers.
    Goldstein LJ; Gottesman MM; Pastan I
    Cancer Treat Res; 1991; 57():101-19. PubMed ID: 1686712
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular diagnosis of multidrug resistance.
    Herzog CE; Bates SE
    Cancer Treat Res; 1994; 73():129-47. PubMed ID: 7710903
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.
    Lee WP; Lee CL
    Oncology; 1994; 51(1):2-8. PubMed ID: 7903440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance in human cancer.
    Goldstein LJ; Pastan I; Gottesman MM
    Crit Rev Oncol Hematol; 1992; 12(3):243-53. PubMed ID: 1353966
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of a distinctive P-glycoprotein-mediated resistance phenotype in human ovarian carcinoma cells after their in vitro exposure to fractionated X-irradiation.
    Hill BT; Whelan RD; Hurst HC; McClean S
    Cancer; 1994 Jun; 73(12):2990-9. PubMed ID: 7911070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Methods for studying pleiotropic drug resistance (multidrug resistance, MDR)].
    Gobbi M; Michieli M; Raspadori D; Damiani D; Michelutti A; Pierri I; Tazzari PL
    Haematologica; 1991 Jun; 76 Suppl 3():150-3. PubMed ID: 1684338
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of 300-kilodalton membrane protein in adriamycin-resistant human tumor cells by a monoclonal antibody MRK18.
    Sugimoto Y; Okochi E; Hamada H; Oh-hara T; Tsuruo T
    Biochem Biophys Res Commun; 1990 Jun; 169(2):686-91. PubMed ID: 1972622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein and tumor progression.
    Benchimol S; Ling V
    J Natl Cancer Inst; 1994 Jun; 86(11):814-6. PubMed ID: 7910218
    [No Abstract]   [Full Text] [Related]  

  • 10. Expression of MDR1/P glycoprotein in human sarcomas.
    Vergier B; Cany L; Bonnet F; Robert J; de Mascarel A; Coindre JM
    Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of P-glycoprotein in drug-resistant hematologic malignancies.
    Dalton WS; Grogan TM; Miller TP
    Cancer Treat Res; 1991; 57():187-208. PubMed ID: 1686717
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution of multi-drug resistance-associated P-glycoprotein in normal and neoplastic human tissues. Analysis with 3 monoclonal antibodies recognizing different epitopes of the P-glycoprotein molecule.
    van der Valk P; van Kalken CK; Ketelaars H; Broxterman HJ; Scheffer G; Kuiper CM; Tsuruo T; Lankelma J; Meijer CJ; Pinedo HM
    Ann Oncol; 1990; 1(1):56-64. PubMed ID: 1706611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-directed therapy of multidrug-resistant tumor cells.
    Efferth T; Volm M
    Med Oncol Tumor Pharmacother; 1992; 9(1):11-9. PubMed ID: 1285219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of P-glycoprotein with four monoclonal antibodies in normal and tumor tissues.
    Pavelic ZP; Reising J; Pavelic L; Kelley DJ; Stambrook PJ; Gluckman JL
    Arch Otolaryngol Head Neck Surg; 1993 Jul; 119(7):753-7. PubMed ID: 8100425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR-1 gene expression, anthracycline retention and cytotoxicity in human lung-tumor cells from refractory patients.
    Ramachandran C; Sauerteig A; Sridhar KS; Thurer RJ; Krishan A
    Cancer Chemother Pharmacol; 1993; 31(6):431-41. PubMed ID: 8095859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation between C219 and drug resistance in lung neoplasms].
    Oddi G; De Angelis G; Alma MG; De Marinis F; Bigioni D
    Minerva Med; 1993 Apr; 84(4):179-82. PubMed ID: 8099431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-transporter proteins in clinical multidrug resistance.
    Scheper RJ; Broxterman HJ; Scheffer GL; Meijer CJ; Pinedo HM
    Clin Chim Acta; 1992 Mar; 206(1-2):25-32. PubMed ID: 1349270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on low-level MDR cells.
    Belvedere G; Dolfini E
    Cytotechnology; 1993; 12(1-3):257-64. PubMed ID: 7765328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P-glycoprotein is strongly expressed in brain capillaries.
    Jetté L; Béliveau R
    Adv Exp Med Biol; 1993; 331():121-5. PubMed ID: 8101423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.